Susan Cleator

Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer

Ian Kunkler, Nicola S. Russell, Niall Anderson, R Sainsbury et autres

gb, nl, au, cn, tw (code pays fourni par la source)

Menopausal hormone therapy for breast cancer patients: what is the current evidence?

Sarah Glynne, James A. Simon, Stephen J. Payne, Louise Newson et autres

gb, us (code pays fourni par la source)

Abstract P3-01-18: Clinical validation of image-based AI predictive biomarkers for precision neoadjuvant triple-negative breast cancer treatment (PEAR-TNBC): Interim results from Cohort A

Peter E. Hall, Matthew Williams, Eleonora Peerani, El Li Tham et autres

Abstract GS2-03: Does postmastectomy radiotherapy in 'intermediate-risk' breast cancer impact overall survival? 10 year results of the BIG 2-04 MRC SUPREMO randomised trial: on behalf of the SUPREMO trial investigators

Ian Kunkler, Nicola S. Russell, Niall Anderson, Fidelis Muturi et autres

Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study

Adrian Murray Brunt, Fay Cafferty, Duncan Wheatley, Mark Sydenham et autres

gb, us (code pays fourni par la source)

Needs assessment of family history pathway with chemoprevention extension for unaffected women with a moderate or high risk of breast cancer

Katy Hogben, Susan Cleator, Francis P. Henry

gb (code pays fourni par la source)

Impact of boost radiation for close margins following breast conservation for ductal carcinoma in-situ

Ahmed Ezzat, Dhurka Shanthakumar, Naomi Laskar, Ramsey Cutress et autres

gb (code pays fourni par la source)

607 FAST-Forward nodal substudy: 5-year normal tissue effects following 1-week versus 3-week axillary radiotherapy for breast cancer (ISRCTN19906132)

Adrian Murray Brunt, Duncan Wheatley, Jaymini Patel, Fay Cafferty et autres

5025 Hypofractionated breast radiotherapy for 1 week vs 3 weeks: 10-year efficacy and late normal tissue effects in the FAST-Forward randomised trial

Adrian Murray Brunt, Fay Cafferty, Duncan Wheatley, Jaymini Patel et autres

Impact of resection margin width on local recurrence following breast-conserving surgery and whole breast radiotherapy for pure ductal carcinoma in situ: a systematic review and meta-analysis

Ahmed Ezzat, Dhurka Shanthakumar, Naomi Laskar, Ramsey Cutress et autres

gb (code pays fourni par la source)

Response adapted de-escalation of neo-adjuvant therapy for intermediate risk HER2-positive early breast cancer: an institutional experience

T. Talbot, Farah Rehman, Laura Kenny, V Harding et autres

gb (code pays fourni par la source)

Developing a functional precision medicine assay to predict pathological complete response in patients with triple-negative breast cancer: Interim results from the PEAR-TNBC Trial

Peter E. Hall, Matthew Williams, Eleonora Peerani, El Li Tham et autres

in, us, gb (code pays fourni par la source)